TTC5 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.67201841050746E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.45980000035395E-07 |
Normal-vs-Stage2 |
3.808300E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
9.584700E-03 |
Stage1-vs-Stage2 |
6.813200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.343200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.923400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.69670010952939E-10 |
Normal-vs-AfricanAmerican |
7.682100E-02 |
Normal-vs-Asian |
3.77709996612907E-09 |
Caucasian-vs-AfricanAmerican |
6.054600E-01 |
Caucasian-vs-Asian |
8.468400E-01 |
AfricanAmerican-vs-Asian |
3.158800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.54129999999186E-06 |
Normal-vs-Female |
3.73859999958093E-07 |
Male-vs-Female |
3.954600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.064650E-03 |
Normal-vs-Extreme_Weight |
3.26059999999906E-06 |
Normal-vs-Obese |
8.177700E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.851800E-01 |
Normal_Weight-vs-Obese |
2.400100E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.283600E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.688790E-01 |
Normal-vs-Age(41-60Yrs) |
7.75120000000573E-05 |
Normal-vs-Age(61-80Yrs) |
5.56600000534146E-08 |
Normal-vs-Age(81-100Yrs) |
3.418400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.019000E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.101700E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.901170E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.275000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.582400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.975400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.081400E-01 |
Normal-vs-Grade 3 |
2.680600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.198400E-01 |
Grade 2-vs-Grade 4 |
2.081400E-01 |
Grade 3-vs-Grade 4 |
2.680600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.27140001146853E-09 |
Normal-vs-N1 |
1.535900E-02 |
N0-vs-N1 |
3.363900E-02 |
|
|